The quantitative analysis of CCR2 protein signal in marker-defined tumor tissue compartments showed significantly higher levels in CD11b+ myeloid cells than in CK− (nontumor) stromal areas and CK+ cancer cell nests; and this was consistent across the different tumor types analyzed (Fig. 6D). The gene discussed is CCR2; the disease is neoplasm.